Defense Verdict Returned In Connecticut Pradaxa Wrongful Death Trial
HARTFORD, Conn. — A Connecticut state court jury on March 23 said Boehringer Ingelheim Pharmaceuticals Inc. failed to provide an adequate warning that its Pradaxa anticoagulant could cause uncontrolled internal bleeding...To view the full article, register now.
Already a subscriber? Click here to view full article